dreamproit/uscode huggingface dataset:
19 U.S.C. § 1436a (CUSTOMS DUTIES)
§ 1436a. Report on violations of arrival, reporting, entry, and clearance requirements and falsity or lack of manifest
(a) In general
The Commissioner of U.S. Customs and Border Protection shall submit to the appropriate congressional committees an annual report that contains the information described in subsection (b) with respect to each violation of section 1436 of this title, as amended by section 8007, and section 1584 of this title that occurred during the previous year.
(b) Information described
The information described in this subsection is the following:
(1) The name and address of the violator.
(2) The specific violation that was committed.
(3) The location or port of entry through which the items were transported.
(4) An inventory of the items seized, including a description of the items and the quantity seized.
(5) The location from which the items originated.
(6) The entity responsible for the apprehension or seizure, organized by location or port of entry.
(7) The amount of penalties assessed by U.S. Customs and Border Protection, organized by name of the violator and location or port of entry.
(8) The amount of penalties that U.S. Customs and Border Protection could have levied, organized by name of the violator and location or port of entry.
(9) The rationale for negotiating lower penalties, organized by name of the violator and location or port of entry.
(c) Appropriate congressional committees defined
In this section, the term “appropriate congressional committees” means—
(1) the Committee on Finance and the Committee on Homeland Security and Governmental Affairs of the Senate; and
(2) the Committee on Ways and Means, the Committee on Oversight and Government Reform, and the Committee on Homeland Security of the House of Representatives.
(Pub. L. 115–271, title VIII, § 8008, Oct. 24, 2018, 132 Stat. 4081.)
heading: References in Text
text: Section 1436 of this title, as amended by section 8007, referred to in subsec. (a), is section 1436 of this title as amended by section 8007 of Pub. L. 115–271.
heading: Codification
text: Section was enacted as part of the Synthetics Trafficking and Overdose Prevention Act of 2018, also known as the STOP Act of 2018, and also as part of the Substance Use–Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act, also known as the SUPPORT for Patients and Communities Act, and not as part of the Tariff Act of 1930 which comprises this chapter.
19 U.S.C. § 1583a (CUSTOMS DUTIES)
§ 1583a. Development of technology to detect illicit narcotics
(a) In general
The Postmaster General and the Commissioner of U.S. Customs and Border Protection, in coordination with the heads of other agencies as appropriate, shall collaborate to identify and develop technology for the detection of illicit fentanyl, other synthetic opioids, and other narcotics and psychoactive substances entering the United States by mail.
(b) Outreach to private sector
The Postmaster General and the Commissioner shall conduct outreach to private sector entities to gather information regarding the current state of technology to identify areas for innovation relating to the detection of illicit fentanyl, other synthetic opioids, and other narcotics and psychoactive substances entering the United States.
(Pub. L. 115–271, title VIII, § 8006, Oct. 24, 2018, 132 Stat. 4080.)
heading: Codification
text: Section was enacted as part of the Synthetics Trafficking and Overdose Prevention Act of 2018, also known as the STOP Act of 2018, and also as part of the Substance Use–Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act, also known as the SUPPORT for Patients and Communities Act, and not as part of the Tariff Act of 1930 which comprises this chapter.
21 U.S.C. § 813 (FOOD AND DRUGS)
§ 813. Treatment of controlled substance analogues
(a) In general
A controlled substance analogue shall, to the extent intended for human consumption, be treated, for the purposes of any Federal law as a controlled substance in schedule I.
(b) Determination
In determining whether a controlled substance analogue was intended for human consumption under subsection (a), the following factors may be considered, along with any other relevant factors:
(1) The marketing, advertising, and labeling of the substance.
(2) The known efficacy or usefulness of the substance for the marketed, advertised, or labeled purpose.
(3) The difference between the price at which the substance is sold and the price at which the substance it is purported to be or advertised as is normally sold.
(4) The diversion of the substance from legitimate channels and the clandestine importation, manufacture, or distribution of the substance.
(5) Whether the defendant knew or should have known the substance was intended to be consumed by injection, inhalation, ingestion, or any other immediate means.
(6) Any controlled substance analogue that is manufactured, formulated, sold, distributed, or marketed with the intent to avoid the provisions of existing drug laws.
(c) Limitation
For purposes of this section, evidence that a substance was not marketed, advertised, or labeled for human consumption, by itself, shall not be sufficient to establish that the substance was not intended for human consumption.
(Pub. L. 91–513, title II, § 203, as added Pub. L. 99–570, title I, § 1202, Oct. 27, 1986, 100 Stat. 3207–13; amended Pub. L. 100–690, title VI, § 6470(c), Nov. 18, 1988, 102 Stat. 4378; Pub. L. 115–271, title III, § 3241, Oct. 24, 2018, 132 Stat. 3950.)
heading: References in Text
text: Schedule I, referred to in subsec. (a), is set out in section 812(c) of this title.
heading: Amendments
text: 2018—Pub. L. 115–271 designated existing provisions as subsec. (a), inserted heading, and added subsecs. (b) and (c).
1988—Pub. L. 100–690 substituted “any Federal law” for “this subchapter and subchapter II of this chapter”.
21 U.S.C. § 832 (FOOD AND DRUGS)
§ 832. Suspicious orders
(a) Reporting
Each registrant shall—
(1) design and operate a system to identify suspicious orders for the registrant;
(2) ensure that the system designed and operated under paragraph (1) by the registrant complies with applicable Federal and State privacy laws; and
(3) upon discovering a suspicious order or series of orders, notify the Administrator of the Drug Enforcement Administration and the Special Agent in Charge of the Division Office of the Drug Enforcement Administration for the area in which the registrant is located or conducts business.
(b) Suspicious order database
(1) In general
Not later than 1 year after October 24, 2018, the Attorney General shall establish a centralized database for collecting reports of suspicious orders.
(2) Satisfaction of reporting requirements
If a registrant reports a suspicious order to the centralized database established under paragraph (1), the registrant shall be considered to have complied with the requirement under subsection (a)(3) to notify the Administrator of the Drug Enforcement Administration and the Special Agent in Charge of the Division Office of the Drug Enforcement Administration for the area in which the registrant is located or conducts business.
(c) Sharing information with the States
(1) In general
The Attorney General shall prepare and make available information regarding suspicious orders in a State, including information in the database established under subsection (b)(1), to the point of contact for purposes of administrative, civil, and criminal oversight relating to the diversion of controlled substances for the State, as designated by the Governor or chief executive officer of the State.
(2) Timing
The Attorney General shall provide information in accordance with paragraph (1) within a reasonable period of time after obtaining the information.
(3) Coordination
In establishing the process for the provision of information under this subsection, the Attorney General shall coordinate with States to ensure that the Attorney General has access to information, as permitted under State law, possessed by the States relating to prescriptions for controlled substances that will assist in enforcing Federal law.
(Pub. L. 91–513, title II, § 312, as added Pub. L. 115–271, title III, § 3292(b), Oct. 24, 2018, 132 Stat. 3956.)
21 U.S.C. § 1503...1505 (FOOD AND DRUGS)
§§ 1503 to 1505. Repealed. Pub. L. 100–690, title I, § 1009, Nov. 18, 1988, 102 Stat. 4188, as amended by Pub. L. 105–20, § 2(b), June 27, 1997, 111 Stat. 234
text: Section 1503, Pub. L. 100–690, title I, § 1004, Nov. 18, 1988, 102 Stat. 4184, related to coordination between Office of National Drug Control Policy and executive branch departments and agencies. See section 1704 of this title.
text: Section 1504, Pub. L. 100–690, title I, § 1005, Nov. 18, 1988, 102 Stat. 4185; Pub. L. 103–322, title IX, § 90203, Sept. 13, 1994, 108 Stat. 1991; Pub. L. 105–20, § 2(b), June 27, 1997, 111 Stat. 234, related to annual development and submission of National Drug Control Strategy by President to Congress. See section 1705 of this title.
text: Section 1505, Pub. L. 100–690, title I, § 1008, formerly § 1003A, as added Pub. L. 101–510, div. A, title X, § 1011, Nov. 5, 1990, 104 Stat. 1633; renumbered § 1008 and amended Pub. L. 103–322, title IX, § 90204(a), (b), (c)(2), (3), Sept. 13, 1994, 108 Stat. 1993, 1994, established Counter-Drug Technology Assessment Center within Office of National Drug Control Policy.
text: A prior section 1505, Pub. L. 100–690, title I, § 1008, Nov. 18, 1988, 102 Stat. 4188, provided for an executive reorganization study and report to Congress and the President no later than Jan. 15, 1990, prior to repeal by Pub. L. 103–322, § 90204(c)(1).
heading: Effective Date of Repeal
text: Repeal effective Sept. 30, 1997, see section 1009 of Pub. L. 100–690, as amended, which was formerly classified to section 1506 of this title.
21 U.S.C. § 1506...1508 (FOOD AND DRUGS)
§§ 1506 to 1508. Repealed. Pub. L. 100–690, title I, § 1009, Nov. 18, 1988, 102 Stat. 4188, as amended by Pub. L. 105–20, § 2(b), June 27, 1997, 111 Stat. 234; Pub. L. 115–271, title VIII, § 8203(a)(3), Oct. 24, 2018, 132 Stat. 4111
text: Section 1506, Pub. L. 100–690, title I, § 1009, Nov. 18, 1988, 102 Stat. 4188; Pub. L. 103–322, title IX, § 90208(a), Sept. 13, 1994, 108 Stat. 1995; Pub. L. 105–20, § 2(b), June 27, 1997, 111 Stat. 234; Pub. L. 115–271, title VIII, § 8203(a)(3), Oct. 24, 2018, 132 Stat. 4111, repealed this subchapter, and the amendments made by this subchapter, except for section 1007, effective Sept. 30, 1997. Amendment by Pub. L. 115–271 added another exception for sections 1021 to 1035 of Pub. L. 100–690 [21 U.S.C. 1521 to 1535], which was not given effect because those sections had not been treated as repealed in light of Pub. L. 105–20, § 2(b).
text: Section 1507, Pub. L. 100–690, title I, § 1010, Nov. 18, 1988, 102 Stat. 4188; Pub. L. 105–20, § 2(b), June 27, 1997, 111 Stat. 234, defined terms for purposes of this subchapter. See section 1701 of this title.
text: Section 1508, Pub. L. 100–690, title I, § 1011, Nov. 18, 1988, 102 Stat. 4189; Pub. L. 103–322, title IX, § 90206, Sept. 13, 1994, 108 Stat. 1995; Pub. L. 105–20, § 2(b), June 27, 1997, 111 Stat. 234, authorized appropriations to carry out this subchapter. See section 1711 of this title.
heading: Effective Date of Repeal
text: Repeal effective Sept. 30, 1997, see section 1009 of Pub. L. 100–690, as amended, which was formerly classified to section 1506 of this title.
21 U.S.C. § 1522 (FOOD AND DRUGS)
§ 1522. Purposes
The purposes of this subchapter are—
(1) to reduce substance use and misuse among youth in communities throughout the United States, and over time, to reduce substance use and misuse among adults;
(2) to strengthen collaboration among communities, the Federal Government, and State, local, and tribal governments;
(3) to enhance intergovernmental cooperation and coordination on the issue of substance use and misuse among youth;
(4) to serve as a catalyst for increased citizen participation and greater collaboration among all sectors and organizations of a community that first demonstrates a long-term commitment to reducing substance use and misuse among youth;
(5) to rechannel resources from the fiscal year 1998 Federal drug control budget to provide technical assistance, guidance, and financial support to communities that demonstrate a long-term commitment in reducing substance use and misuse among youth;
(6) to disseminate to communities timely information regarding the state-of-the-art practices and initiatives that have proven to be effective in reducing substance use and misuse among youth;
(7) to enhance, not supplant, local community initiatives for reducing substance use and misuse among youth; and
(8) to encourage the creation of and support for community anti-drug coalitions throughout the United States.
(Pub. L. 100–690, title I, § 1022, as added Pub. L. 105–20, § 2(a)(2), June 27, 1997, 111 Stat. 225; amended Pub. L. 115–271, title VIII, § 8203(b)(1), Oct. 24, 2018, 132 Stat. 4111.)
heading: Amendments
text: 2018—Pub. L. 115–271, which directed substitution of “substance use and misuse” for “substance abuse” wherever appearing in section 1022 of “chapter 2 of subtitle A of title I of the National Narcotics Leadership Act of 1988”, was executed to this section, which is section 1022 of chapter 2 of the National Narcotics Leadership Act of 1988, to reflect the probable intent of Congress. The National Narcotics Leadership Act of 1988 is itself subtitle A of title I of Pub. L. 100–690.
21 U.S.C. § 1523 (FOOD AND DRUGS)
§ 1523. Definitions
In this subchapter:
(1) Administrator
The term “Administrator” means the Administrator appointed by the Director under section 1531(c) of this title.
(2) Advisory Commission
The term “Advisory Commission” means the Advisory Commission established under section 1541 1 of this title.
(3) Community
The term “community” shall have the meaning provided that term by the Administrator, in consultation with the Advisory Commission.
(4) Director
The term “Director” means the Director of the Office of National Drug Control Policy.
(5) Eligible coalition
The term “eligible coalition” means a coalition that meets the applicable criteria under section 1532(a) of this title.
(6) Grant recipient
The term “grant recipient” means the recipient of a grant award under section 1532 of this title.
(7) Nonprofit organization
The term “nonprofit organization” means an organization described under section 501(c)(3) of title 26 that is exempt from taxation under section 501(a) of title 26.
(8) Program
The term “Program” means the program established under section 1531(a) of this title.
(9) Substance use and misuse
The term “substance use and misuse” means—
(A) the illegal use or misuse of drugs, including substances for which a listing is effect under any of schedules I through V under section 812 of this title;
(B) the misuse of inhalants or over-the-counter drugs; or
(C) the use of alcohol, tobacco, or other related product as such use is prohibited by State or local law.
(10) Youth
The term “youth” shall have the meaning provided that term by the Administrator, in consultation with the Advisory Commission.
(Pub. L. 100–690, title I, § 1023, as added Pub. L. 105–20, § 2(a)(2), June 27, 1997, 111 Stat. 225; amended Pub. L. 115–271, title VIII, § 8203(b)(2), Oct. 24, 2018, 132 Stat. 4111.)
heading: References in Text
text: Section 1541 of this title, referred to in par. (2), was repealed by Pub. L. 115–271, title VIII, § 8203(b)(5), Oct. 24, 2018, 132 Stat. 4112.
heading: Amendments
text: 2018—Par. (9). Pub. L. 115–271, which directed adding par. (9) and striking out former par. (9), which defined “substance abuse”, in section 1023 of “chapter 2 of subtitle A of title I of the National Narcotics Leadership Act of 1988”, was executed to this section, which is section 1023 of chapter 2 of the National Narcotics Leadership Act of 1988, to reflect the probable intent of Congress. The National Narcotics Leadership Act of 1988 is itself subtitle A of title I of Pub. L. 100–690.
21 U.S.C. § 1524 (FOOD AND DRUGS)
§ 1524. Authorization of appropriations
(a) In general
There is authorized to be appropriated to the Office of National Drug Control Policy to carry out this subchapter $99,000,000 for each of fiscal years 2018 through 2023.
(b) Administrative costs
Not more than 8 percent of the funds appropriated to carry out this subchapter may be used by the Office of National Drug Control Policy to pay administrative costs associated with the responsibilities of the Office under this subchapter.
(Pub. L. 100–690, title I, § 1024, as added Pub. L. 105–20, § 2(a)(2), June 27, 1997, 111 Stat. 226; amended Pub. L. 107–82, § 1(b), (c), Dec. 14, 2001, 115 Stat. 817; Pub. L. 109–469, title VIII, § 801, Dec. 29, 2006, 120 Stat. 3535; Pub. L. 115–271, title VIII, § 8203(a)(4)(A), (b)(3), Oct. 24, 2018, 132 Stat. 4111.)
heading: Amendments
text: 2018—Pub. L. 115–271, § 8203(b)(3), which directed adding subsecs. (a) and (b) and striking out former subsecs. (a) and (b), which related to authorization of appropriations and administrative costs, respectively, in section 1024 of “chapter 2 of subtitle A of title I of the National Narcotics Leadership Act of 1988”, was executed to this section, which is section 1024 of chapter 2 of the National Narcotics Leadership Act of 1988, to reflect the probable intent of Congress. The National Narcotics Leadership Act of 1988 is itself subtitle A of title I of Pub. L. 100–690.
2018—Pub. L. 115–271, § 8203(a)(4)(A), amended directory language of Pub. L. 109–469, § 801. See 2006 Amendment notes below.
2006—Subsec. (a)(11) to (15). Pub. L. 109–469, § 801(a), as amended by Pub. L. 115–271, § 8203(a)(4)(A), added pars. (11) to (15).
Subsec. (b). Pub. L. 109–469, § 801(b), as amended by Pub. L. 115–271, § 8203(a)(4)(A), amended subsec. (b) generally. Prior to amendment, text read as follows: “Not more than the following percentages of the amounts authorized under subsection (a) of this section may be used to pay administrative costs:
“(1) 10 percent for fiscal year 1998.
“(2) 6 percent for fiscal year 1999.
“(3) 4 percent for fiscal year 2000.
“(4) 3 percent for fiscal year 2001.
“(5) 6 percent for each of fiscal years 2002 through 2007.”
2001—Subsec. (a)(5) to (10). Pub. L. 107–82, § 1(b), added pars. (5) to (10) and struck out former par. (5) which read as follows: “$43,500,000 for fiscal year 2002.”
Subsec. (b)(5). Pub. L. 107–82, § 1(c), added par. (5) and struck out former par. (5) which read as follows: “3 percent for fiscal year 2002.”
heading: Effective Date of 2018 Amendment
text: Pub. L. 115–271, title VIII, § 8203(a)(4)(B), Oct. 24, 2018, 132 Stat. 4111, provided that: “The amendments made by subparagraph (A) [amending this section, section 1532 of this title, and provisions set out as a note under section 1532 of this title] shall take effect as though enacted as part of the Office of National Drug Control Policy Reauthorization Act of 2006 (Public Law 109–469; 120 Stat. 3502).”
21 U.S.C. § 1531 (FOOD AND DRUGS)
§ 1531. Establishment of drug-free communities support program
(a) Establishment
The Director shall establish a program to support communities in the development and implementation of comprehensive, long-term plans and programs to prevent and treat substance use and misuse among youth.
(b) Program
In carrying out the Program, the Director shall—
(1) make and track grants to grant recipients;
(2) provide for technical assistance and training, data collection, and dissemination of information on state-of-the-art practices that the Director determines to be effective in reducing substance use and misuse; and
(3) provide for the general administration of the Program.
(c) Administration
Not later than 30 days after receiving recommendations from the Advisory Commission under section 1542(a)(1) 1 of this title, the Director shall appoint an Administrator to carry out the Program.
(d) Contracting
The Director may employ any necessary staff and may enter into contracts or agreements with national drug control agencies, including interagency agreements to delegate authority for the execution of grants and for such other activities necessary to carry out this subchapter.
(Pub. L. 100–690, title I, § 1031, as added Pub. L. 105–20, § 2(a)(2), June 27, 1997, 111 Stat. 226; amended Pub. L. 115–271, title VIII, § 8203(b)(4)(A), Oct. 24, 2018, 132 Stat. 4111.)
heading: References in Text
text: Section 1542(a)(1) of this title, referred to in subsec. (c), was repealed by Pub. L. 115–271, title VIII, § 8203(b)(5), Oct. 24, 2018, 132 Stat. 4112.
heading: Amendments
text: 2018—Subsecs. (a), (b)(2). Pub. L. 115–271, which directed substitution of “substance use and misuse” for “substance abuse” wherever appearing in subchapter I of “chapter 2 of subtitle A of title I of the National Narcotics Leadership Act of 1988”, was executed throughout part A of this subchapter, which is subchapter I of chapter 2 of the National Narcotics Leadership Act of 1988, to reflect the probable intent of Congress. The National Narcotics Leadership Act of 1988 is itself subtitle A of title I of Pub. L. 100–690.
21 U.S.C. § 1541...1548 (FOOD AND DRUGS)
§§ 1541 to 1548 Repealed. Pub. L. 115–271, title VIII, § 8203(b)(5), Oct. 24, 2018, 132 Stat. 4112
text: Section 1541, Pub. L. 100–690, title I, § 1041, as added Pub. L. 105–20, § 2(a)(2), June 27, 1997, 111 Stat. 231, established Advisory Commission on Drug-Free Communities.
text: Section 1542, Pub. L. 100–690, title I, § 1042, as added Pub. L. 105–20, § 2(a)(2), June 27, 1997, 111 Stat. 231, related to duties of the Commission.
text: Section 1543, Pub. L. 100–690, title I, § 1043, as added Pub. L. 105–20, § 2(a)(2), June 27, 1997, 111 Stat. 232, related to membership of the Commission.
text: Section 1544, Pub. L. 100–690, title I, § 1044, as added Pub. L. 105–20, § 2(a)(2), June 27, 1997, 111 Stat. 232, related to compensation.
text: Section 1545, Pub. L. 100–690, title I, § 1045, as added Pub. L. 105–20, § 2(a)(2), June 27, 1997, 111 Stat. 233, related to terms of office.
text: Section 1546, Pub. L. 100–690, title I, § 1046, as added Pub. L. 105–20, § 2(a)(2), June 27, 1997, 111 Stat. 233, related to Commission meetings.
text: Section 1547, Pub. L. 100–690, title I, § 1047, as added Pub. L. 105–20, § 2(a)(2), June 27, 1997, 111 Stat. 233, related to Commission staff.
text: Section 1548, Pub. L. 100–690, title I, § 1048, as added Pub. L. 105–20, § 2(a)(2), June 27, 1997, 111 Stat. 234; amended Pub. L. 107–82, § 3, Dec. 14, 2001, 115 Stat. 820, terminated the Commission at the end of fiscal year 2007.
heading: Codification
text: Pub. L. 115–271, § 8203(b)(5), which directed the repeal of subchapter II (21 U.S.C. 1541 et seq.) of “chapter 2 of subtitle A of title I of the National Narcotics Leadership Act of 1988”, was executed by repealing part B of this subchapter, which was subchapter II of chapter 2 of the National Narcotics Leadership Act of 1988, to reflect the probable intent of Congress. The National Narcotics Leadership Act of 1988 is itself subtitle A of title I of Pub. L. 100–690.
21 U.S.C. § 1707 (FOOD AND DRUGS)
§ 1707. Repealed. Pub. L. 115–271, title VIII, § 8222(3), Oct. 24, 2018, 132 Stat. 4143
text: Section, Pub. L. 105–277, div. C, title VII, §§ 708, 715, Oct. 21, 1998, 112 Stat. 2681–687, 2681–693; Pub. L. 109–469, title IV, § 401, title VI, § 602, Dec. 29, 2006, 120 Stat. 3525, 3533; Pub. L. 115–271, title VIII, §§ 8202(a), (b)(2), Oct. 24, 2018, 132 Stat. 4110, related to Counter-Drug Technology Assessment Center.